603439 三力制药
交易中 09-15 13:04:36
资讯
新帖
简况
9月14日三力制药涨9.97%，华夏睿阳一年持有混合基金重仓该股
证券之星 · 09-14 16:35
9月14日三力制药涨9.97%，华夏睿阳一年持有混合基金重仓该股
9月11日三力制药涨10.00%，华夏睿阳一年持有混合基金重仓该股
证券之星 · 09-11
9月11日三力制药涨10.00%，华夏睿阳一年持有混合基金重仓该股
异动快报：三力制药（603439）9月11日14点22分触及涨停板
证券之星 · 09-11
异动快报：三力制药（603439）9月11日14点22分触及涨停板
每周股票复盘：三力制药（603439）股东户数降25.24%，净利下滑55.24%
证券之星 · 08-30
每周股票复盘：三力制药（603439）股东户数降25.24%，净利下滑55.24%
三力制药（603439）2026年中报简析：净利润同比下降55.24%
证券之星 · 08-29
三力制药（603439）2026年中报简析：净利润同比下降55.24%
三力制药（603439）披露2026年半年度报告及摘要，8月27日股价下跌0.32%
证券之星 · 08-27
三力制药（603439）披露2026年半年度报告及摘要，8月27日股价下跌0.32%
图解三力制药中报：第二季度单季净利润同比下降117.59%
证券之星 · 08-27
图解三力制药中报：第二季度单季净利润同比下降117.59%
三力制药(603439)6月30日股东户数1.87万户，较上期减少25.24%
证券之星 · 08-27
三力制药(603439)6月30日股东户数1.87万户，较上期减少25.24%
三力制药2026年半年报：现金流大幅改善，营收净利双降
蓝鲸财经 · 08-27
三力制药2026年半年报：现金流大幅改善，营收净利双降
三力制药业绩断崖下跌：提价反噬、并购埋雷叠加债务承压三重困局
新浪证券 · 08-07
三力制药业绩断崖下跌：提价反噬、并购埋雷叠加债务承压三重困局
股市必读：新发布《北京德皓国际会计师事务所(特殊普通合伙)关于上海证券交易所《关于对贵州三力制药股份有限公司2025年年度报告的信息披露监管问询函》的回复》
证券之星 · 07-27
股市必读：新发布《北京德皓国际会计师事务所(特殊普通合伙)关于上海证券交易所《关于对贵州三力制药股份有限公司2025年年度报告的信息披露监管问询函》的回复》
每周股票复盘：三力制药（603439）净利降83%拟注销509万股
证券之星 · 07-26
每周股票复盘：三力制药（603439）净利降83%拟注销509万股
三力制药（603439）披露关于上海证券交易所对公司2025年年度报告信息披露监管问询函的回复公告，7月23日股价上涨1.61%
证券之星 · 07-23
三力制药（603439）披露关于上海证券交易所对公司2025年年度报告信息披露监管问询函的回复公告，7月23日股价上涨1.61%
三力制药（603439）披露股权激励限制性股票回购注销实施公告，7月21日股价下跌3.52%
证券之星 · 07-21
三力制药（603439）披露股权激励限制性股票回购注销实施公告，7月21日股价下跌3.52%
每周股票复盘：三力制药（603439）上半年净利预降45.82%-61.47%
证券之星 · 07-19
每周股票复盘：三力制药（603439）上半年净利预降45.82%-61.47%
三力制药（603439）披露2026年半年度业绩预减公告，7月14日股价下跌0.35%
证券之星 · 07-14
三力制药（603439）披露2026年半年度业绩预减公告，7月14日股价下跌0.35%
每周股票复盘：三力制药（603439）控股股东一致行动人质押2.80%股份
证券之星 · 07-05
每周股票复盘：三力制药（603439）控股股东一致行动人质押2.80%股份
三力制药（603439）披露控股股东之一致行动人部分股份质押公告，7月2日股价下跌0.44%
证券之星 · 07-02
三力制药（603439）披露控股股东之一致行动人部分股份质押公告，7月2日股价下跌0.44%
7月1日三力制药涨6.98%，华夏睿阳一年持有混合基金重仓该股
证券之星 · 07-01
7月1日三力制药涨6.98%，华夏睿阳一年持有混合基金重仓该股
股市必读：三力制药（603439）6月26日收盘跌5.36%，主力净流出3162.49万元
证券之星 · 06-29
股市必读：三力制药（603439）6月26日收盘跌5.36%，主力净流出3162.49万元
加载更多
公司概况
公司名称：
贵州三力制药股份有限公司
所属行业：
医药制造业
上市日期：
2020-04-28
主营业务：
贵州三力制药股份有限公司的主营业务是药品的研发、生产及销售。公司的主要产品是开喉剑喷雾剂（儿童型）、开喉剑喷雾剂、芪胶升白胶囊、妇科再造丸、止嗽化痰丸、黄芪颗粒、强力天麻杜仲胶囊。
发行价格：
7.35
{"stockData":{"symbol":"603439","market":"SH","secType":"STK","nameCN":"三力制药","latestPrice":14.94,"timestamp":1789448676000,"preClose":13.79,"halted":0,"volume":48228385,"delay":0,"changeRate":0.0834,"floatShares":404000000,"shares":404000000,"eps":0.001,"marketStatus":"交易中","change":1.15,"latestTime":"09-15 13:04:36","open":15.17,"high":15.17,"low":13.58,"amount":698000000,"amplitude":0.1153,"askPrice":14.92,"askSize":6,"bidPrice":14.89,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.001,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1789455600000},"marketStatusCode":2,"adr":0,"adjPreClose":13.79,"symbolType":"stock","openAndCloseTimeList":[[1789435800000,1789443000000],[1789448400000,1789455600000]],"highLimit":15.17,"lowLimit":12.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":403840216,"isCdr":false,"pbRate":3.8,"roa":"--","peRate":14940,"roe":"2.54%","epsLYR":0.11,"committee":0.053691,"marketValue":6033000000,"turnoverRate":0.1194,"status":0,"floatMarketCap":6033000000},"requestUrl":"/m/hq/s/603439","defaultTab":"news","newsList":[{"id":"2667659284","title":"9月14日三力制药涨9.97%，华夏睿阳一年持有混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659284","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667659284?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:35","pubTimestamp":1789374940,"startTime":"0","endTime":"0","summary":"证券之星消息，9月14日三力制药涨9.97%，收盘报13.79元，换手率7.79%，成交量31.47万手，成交额4.21亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华夏基金的华夏睿阳一年持有混合。华夏睿阳一年持有混合目前规模为7.12亿元，最新净值1.048，较上一交易日下跌1.73%，近一年上涨21.51%。华夏睿阳一年持有混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666547676","title":"9月11日三力制药涨10.00%，华夏睿阳一年持有混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666547676","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666547676?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:33","pubTimestamp":1789115610,"startTime":"0","endTime":"0","summary":"证券之星消息，9月11日三力制药涨10.00%，收盘报12.54元，换手率5.48%，成交量22.14万手，成交额2.61亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为华夏基金的华夏睿阳一年持有混合。华夏睿阳一年持有混合目前规模为7.12亿元，最新净值1.0664，较上一交易日下跌1.9%，近一年上涨21.51%。华夏睿阳一年持有混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100035586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666549617","title":"异动快报：三力制药（603439）9月11日14点22分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2666549617","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666549617?lang=zh_cn&edition=full","pubTime":"2026-09-11 14:30","pubTimestamp":1789108256,"startTime":"0","endTime":"0","summary":"证券之星9月11日盘中消息，14点22分三力制药（603439）触及涨停板。其所属行业中药目前下跌。领涨股为三力制药。该股为互联网医疗，阿尔茨海默病，中药概念热股。9月10日的资金流向数据方面，主力资金净流出646.86万元，占总成交额7.97%，游资资金净流入705.72万元，占总成交额8.7%，散户资金净流出58.86万元，占总成交额0.73%。近5日资金流向一览见下表：三力制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100028244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043692","title":"每周股票复盘：三力制药（603439）股东户数降25.24%，净利下滑55.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043692","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663043692?lang=zh_cn&edition=full","pubTime":"2026-08-30 07:33","pubTimestamp":1788046394,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，三力制药报收于12.17元，较上周的12.41元下跌1.93%。股本股东变化截至2026年6月30日，公司股东户数为1.87万户，较3月31日减少6303.0户，减幅为25.24%。业绩披露要点2026年中报显示，公司上半年主营收入5.59亿元，同比下降20.31%；归母净利润3718.1万元，同比下降55.24%；扣非净利润4222.9万元，同比下降40.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016570","title":"三力制药（603439）2026年中报简析：净利润同比下降55.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016570","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016570?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:10","pubTimestamp":1787955044,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期三力制药发布2026年中报。根据财报显示，三力制药净利润同比下降55.24%。截至本报告期末，公司营业总收入5.59亿元，同比下降20.31%，归母净利润3718.1万元，同比下降55.24%。持有三力制药最多的基金为华夏睿阳一年持有混合，目前规模为7.12亿元，最新净值1.0939，较上一交易日下跌1.16%，近一年上涨21.51%。本文数据来源于三力制药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900010642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662086872","title":"三力制药（603439）披露2026年半年度报告及摘要，8月27日股价下跌0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086872","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662086872?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:26","pubTimestamp":1787840761,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，三力制药报收于12.47元，较前一交易日下跌0.32%，最新总市值为50.36亿元。该股当日开盘12.45元，最高12.72元，最低12.31元，成交额达9113.26万元，换手率为1.81%。近日，贵州三力制药股份有限公司召开第四届董事会第二十六次会议，审议通过《公司2026年半年度报告及摘要》和《关于制定<对外捐赠管理制度>的议案》。上述议案均获全票通过，会议决议合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700055816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709783","title":"图解三力制药中报：第二季度单季净利润同比下降117.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709783","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662709783?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:08","pubTimestamp":1787828888,"startTime":"0","endTime":"0","summary":"证券之星消息，三力制药2026年中报显示，上半年度公司主营收入5.59亿元，同比下降20.31%；归母净利润3718.1万元，同比下降55.24%；扣非净利润4222.9万元，同比下降40.51%；其中2026年第二季度，公司单季度主营收入1.78亿元，同比下降39.44%；单季度归母净利润-723.06万元，同比下降117.59%；单季度扣非净利润-103.47万元，同比下降103.19%；负债率40.21%，投资收益65.13万元，财务费用882.58万元，毛利率71.24%。财报数据概要请见下图:本文数据来源于三力制药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708321","title":"三力制药(603439)6月30日股东户数1.87万户，较上期减少25.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708321","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662708321?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:58","pubTimestamp":1787824729,"startTime":"0","endTime":"0","summary":"证券之星消息，近日三力制药披露，截至2026年6月30日公司股东户数为1.87万户，较3月31日减少6303.0户，减幅为25.24%。在中药行业个股中，三力制药股东户数低于行业平均水平，截至6月30日，中药行业平均股东户数为5.18万户。从股价来看，2026年3月31日至2026年6月30日，三力制药区间涨幅为15.59%，在此期间股东户数减少6303.0户，减幅为25.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700042549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662597708","title":"三力制药2026年半年报：现金流大幅改善，营收净利双降","url":"https://stock-news.laohu8.com/highlight/detail?id=2662597708","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662597708?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:55","pubTimestamp":1787824523,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月27日讯，8月27日，三力制药 公布2026年中报，公司依托开喉剑喷雾剂等核心品种，受制于终端需求恢复不及预期及行业政策扰动，报告期业绩呈现营收与利润双降态势；同时，公司通过降本增效实现经营现金流大幅改善，并终止实施股权激励计划以优化管理结构。财报数据显示，报告期公司实现营业收入5.59亿元，同比下降20.31%；归母净利润3718.10万元，同比下降55.24%；扣非净利润4222.90万元，同比下降40.51%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787821196043459921","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["159399","SPHQ","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657698283","title":"三力制药业绩断崖下跌：提价反噬、并购埋雷叠加债务承压三重困局","url":"https://stock-news.laohu8.com/highlight/detail?id=2657698283","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657698283?lang=zh_cn&edition=full","pubTime":"2026-08-07 10:44","pubTimestamp":1786070640,"startTime":"0","endTime":"0","summary":"近期三力制药回复上交所2025年年报问询函，完整披露业绩大幅下滑背后的经营与财务隐患。2025年并购标的汉方药业营收同比下滑31.3%、净利润下滑51.31%，公司为此计提1.22亿元商誉减值，减值金额是当年归母净利润的2.5倍，直接吞噬全年利润。公司虽调整营销架构、对汉方药业转向精细化推广，但从2025年年报至2026年半年报预告，业绩下滑趋势并未扭转。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-08-07/doc-inimnenr0061022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["KCE","BK4588","CALF","BK4585","BK0239","XMMO","MYLD","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654061780","title":"股市必读：新发布《北京德皓国际会计师事务所(特殊普通合伙)关于上海证券交易所《关于对贵州三力制药股份有限公司2025年年度报告的信息披露监管问询函》的回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2654061780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654061780?lang=zh_cn&edition=full","pubTime":"2026-07-27 01:26","pubTimestamp":1785086771,"startTime":"0","endTime":"0","summary":"公司公告汇总贵州三力制药股份有限公司关于上海证券交易所对公司2025年年度报告信息披露监管问询函的回复公告三力制药回复上交所关于2025年年度报告的信息披露问询函，涉及业绩下滑、销售费用及商誉减值等问题。北京德皓国际会计师事务所关于上海证券交易所《关于对贵州三力制药股份有限公司2025年年度报告的信息披露监管问询函》的回复贵州三力制药2025年营业收入17.03亿元，同比下降21%；归母净利润0.46亿元，同比下降83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700000707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654405782","title":"每周股票复盘：三力制药（603439）净利降83%拟注销509万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654405782","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654405782?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:14","pubTimestamp":1785003253,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，三力制药报收于9.68元，较上周的10.95元下跌11.6%。本周关注点公司公告汇总：因激励对象离职及业绩未达标，三力制药拟注销5,090,000股限制性股票。同时终止激励计划，回购注销第二、三个解除限售期未解除限售的3,395,000股股票，合计注销5,090,000股，注销日期为2026年7月24日。北京德皓国际会计师事务所就上交所对三力制药2025年年报的问询函回复称，公司2025年营业收入17.03亿元，同比下降21%，归母净利润0.46亿元，同比下降83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653572967","title":"三力制药（603439）披露关于上海证券交易所对公司2025年年度报告信息披露监管问询函的回复公告，7月23日股价上涨1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653572967","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653572967?lang=zh_cn&edition=full","pubTime":"2026-07-23 22:40","pubTimestamp":1784817626,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘，三力制药报收于10.09元，较前一交易日上涨1.61%，最新总市值为41.26亿元。近日，贵州三力制药股份有限公司发布《关于上海证券交易所对公司2025年年度报告信息披露监管问询函的回复公告》。公告显示，公司就上交所关于2025年年度报告的信息披露问询函进行了回复，涉及业绩下滑、销售费用及商誉减值等问题。2025年营收17.03亿元，同比下降21%，归母净利润0.46亿元，同比下降83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300048287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653205992","title":"三力制药（603439）披露股权激励限制性股票回购注销实施公告，7月21日股价下跌3.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653205992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653205992?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:19","pubTimestamp":1784643547,"startTime":"0","endTime":"0","summary":"近日，贵州三力制药股份有限公司发布《股权激励限制性股票回购注销实施公告》。公告显示，因激励对象汤建锋、冯由超离职，以及2024年限制性股票激励计划第一个解除限售期条件未成就，公司决定回购注销240,000股和1,455,000股限制性股票。同时，公司终止实施该激励计划，回购注销第二、三个解除限售期已授予但尚未解除限售的3,395,000股股票。本次合计回购注销5,090,000股，注销日期为2026年7月24日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100044614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230295","title":"每周股票复盘：三力制药（603439）上半年净利预降45.82%-61.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230295?lang=zh_cn&edition=full","pubTime":"2026-07-19 03:03","pubTimestamp":1784401390,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，三力制药报收于10.95元，较上周的11.98元下跌8.6%。本周，三力制药7月15日盘中最高价报12.26元。三力制药当前最新总市值44.78亿元，在中药板块市值排名43/66，在两市A股市值排名3218/5199。本周关注点业绩披露要点：三力制药预计2026年上半年净利同比下降45.82%至61.47%。业绩披露要点三力制药发布业绩预告，预计2026年1-6月归属净利润盈利3200万元至4500万元，较上年同期8,306.10万元减少45.82%到61.47%；扣非后净利润预计为2600万元至3700万元，同比减少47.87%到63.37%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900001015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104890","title":"三力制药（603439）披露2026年半年度业绩预减公告，7月14日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104890","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651104890?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:18","pubTimestamp":1784038701,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，三力制药报收于11.45元，较前一交易日下跌0.35%，最新总市值为46.82亿元。近日，贵州三力制药股份有限公司发布2026年半年度业绩预减公告。公告显示，公司预计2026年半年度实现归属于母公司所有者的净利润为3,200万元到4,500万元，与上年同期8,306.10万元相比减少45.82%到61.47%；扣除非经常性损益后的净利润为2,600万元到3,700万元，同比减少47.87%到63.37%。本次业绩预告未经注册会计师审计。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692225","title":"每周股票复盘：三力制药（603439）控股股东一致行动人质押2.80%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692225","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649692225?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:28","pubTimestamp":1783196892,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：控股股东之一致行动人悦欣医药质押公司2.80%股份公司公告汇总：控股股东及其一致行动人累计质押股份占总股本22.36%公司公告汇总贵州三力制药股份有限公司控股股东之一致行动人悦欣医药将其持有的公司部分股份办理质押，本次质押股份数量为11,450,000股，占其所持股份比例的56.14%，占公司总股本的2.80%。本次质押后，控股股东及其一致行动人累计质押股份91,450,000股，占其合计持股总数的45.89%，占公司总股本的22.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648968677","title":"三力制药（603439）披露控股股东之一致行动人部分股份质押公告，7月2日股价下跌0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648968677","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648968677?lang=zh_cn&edition=full","pubTime":"2026-07-02 23:00","pubTimestamp":1783004443,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，三力制药报收于13.43元，较前一交易日下跌0.44%，最新总市值为54.92亿元。该股当日开盘13.47元，最高13.9元，最低13.3元，成交额达1.97亿元，换手率为3.6%。公告显示，公司控股股东之一致行动人悦欣医药将其持有的公司部分股份办理质押，本次质押股份数量为11,450,000股，占其所持股份比例的56.14%，占公司总股本的2.80%。本次质押融资用途为自身资金需求。质押股份不存在被用于重大资产重组业绩补偿等情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648515720","title":"7月1日三力制药涨6.98%，华夏睿阳一年持有混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648515720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648515720?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:35","pubTimestamp":1782894955,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日三力制药涨6.98%，收盘报13.49元，换手率3.64%，成交量14.7万手，成交额1.92亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华夏基金的华夏睿阳一年持有混合。华夏睿阳一年持有混合目前规模为7.76亿元，最新净值1.1133，较上一交易日上涨0.75%，近一年上涨21.51%。华夏睿阳一年持有混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647834871","title":"股市必读：三力制药（603439）6月26日收盘跌5.36%，主力净流出3162.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647834871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647834871?lang=zh_cn&edition=full","pubTime":"2026-06-29 02:21","pubTimestamp":1782670870,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，三力制药报收于13.24元，下跌5.36%，换手率3.12%，成交量12.59万手，成交额1.72亿元。交易信息汇总：主力资金当日净流出2262.69万元，前10个交易日累计净流出3641.09万元。交易信息汇总股价提醒6月26日三力制药收盘报13.24元，跌5.36%，当日成交1.72亿元。资金流向6月26日主力资金净流出2262.69万元，占总成交额0.0%；游资资金净流入414.71万元，占总成交额0.0%；散户资金净流入1847.98万元，占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900000726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789448680015,"stockEarnings":[{"period":"1week","weight":0.0807},{"period":"1month","weight":0.0192},{"period":"3month","weight":-0.0969},{"period":"6month","weight":0.1963},{"period":"1year","weight":0.0747},{"period":"ytd","weight":0.1841}],"compareEarnings":[{"period":"1week","weight":-0.012},{"period":"1month","weight":-0.0107},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0038},{"period":"ytd","weight":-0.021}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"贵州三力制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18667人(较上一季度减少25.24%)","perCapita":"21633股","listingDate":"2020-04-28","address":"贵州省安顺市平坝区夏云工业园区","registeredCapital":"40384万元","survey":" 贵州三力制药股份有限公司的主营业务是药品的研发、生产及销售。公司的主要产品是开喉剑喷雾剂（儿童型）、开喉剑喷雾剂、芪胶升白胶囊、妇科再造丸、止嗽化痰丸、黄芪颗粒、强力天麻杜仲胶囊。","listedPrice":7.35},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三力制药(603439)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三力制药(603439)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三力制药,603439,三力制药股票,三力制药股票老虎,三力制药股票老虎国际,三力制药行情,三力制药股票行情,三力制药股价,三力制药股市,三力制药股票价格,三力制药股票交易,三力制药股票购买,三力制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三力制药(603439)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三力制药(603439)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}